Hydrus canal stent meets study endpoint

14:00 EST 13 Nov 2017 | Healio

Paul J. Harasymowycz
NEW ORLEANS — Two-year results of the HORIZON study show that 77.2% of patients implanted with a Hydrus microstent achieved the primary endpoint of a 20% reduction in washed-out IOP compared with 57.8% of patients who underwent cataract surgery only.
In the HORIZON study, 556 patients with cataract and mild to moderate glaucoma were randomly assigned to cataract surgery with the Hydrus (Ivantis) or to cataract surgery alone.
“Whenever we do combined surgery, the cataract effect weans off over time and perhaps that’s why these stents are working,” Paul

Original Article: Hydrus canal stent meets study endpoint


More From BioPortfolio on "Hydrus canal stent meets study endpoint"

Quick Search


Relevant Topic

Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...